Results 91 to 100 of about 12,776,407 (326)

Low Molecular Weight Heparin Overdose: A 10 Year Case Series [PDF]

open access: yesAsia Pacific Journal of Medical Toxicology, 2013
Background: Low molecular weight heparin (LMWH) is used for the treatment and prevention of coagulative disorders. Few patients receiving therapeutic doses of LMWH develop major hemorrhage.
Adeline Ngo, Daryl Tan, Kent Olson
doaj  

Tau Aggregate Imaging and Transcriptomics of Alzheimer's Disease Brain at Different Stages of Disease

open access: yesAdvanced Science, EarlyView.
The protein aggregates and gene expression in the middle temporal gyrus (MTG) and somatosensory cortex (SOM) of the postmortem brains of 13 Alzheimer's disease patients were studied in detail, revealing that small hyperphosphorylated tau aggregates increase with Braak stage driven by microglial inflammation.
Elizabeth A. English   +9 more
wiley   +1 more source

Solution Confirmation of UVC-Irradiated Low-Molecular-Weight Heparin

open access: yesPhyschem
Heparin is a highly sulphated polyelectrolyte, and its properties depend strongly on its shape in solution. In this study, we closely examined the structural behaviour of low-molecular-weight heparin under aerobic ultraviolet-C (UVC, 100–280 nm ...
Fathi Elashhab, Lobna Sheha, Nada Elzawi
doaj   +1 more source

Can We Produce Heparin/Heparan Sulfate Biomimetics Using “Mother-Nature” as the Gold Standard?

open access: yesMolecules, 2015
Heparan sulfate (HS) and heparin are glycosaminoglycans (GAGs) that are heterogeneous in nature, not only due to differing disaccharide combinations, but also their sulfate modifications.
Brooke L. Farrugia   +3 more
doaj   +1 more source

Analysis of the Application Value of Low Molecular Weight Heparin Combined with Heparin in Patients with Chorionic Bump in Early Pregnancy [PDF]

open access: yes
Xu-Ting Peng,1 Zhu-Hua Cai,2 Jie Shen,3 Hai-Yan Zhu2 1Department of Gynecology, The Third Affiliated Hospital of Wenzhou Medical University, Wenzhou, People’s Republic of China; 2Department of Gynecology, the First Affiliated Hospital of Wenzhou Medical ...
Shen J, Peng XT, Cai ZH, Zhu HY
core  

AI‐Powered, Temperature‐Resolved Centrifugal Microfluidics for Rapid 3D Phase‐Diagram Generation of Biomolecular Condensates

open access: yesAdvanced Science, EarlyView.
By merging centrifugal microfluidics, precise temperature control, and AI image recognition, T‐PhaseMap transforms biomolecular condensate phase mapping into a rapid, temperature‐resolved workflow. It generates 3D composition–temperature phase diagrams within 30 min, resolves four phase states, and uncovers temperature‐dependent heparin sodium ...
Jiashuo Li   +6 more
wiley   +1 more source

Best Practice for Administering Low Molecular Weight Heparin (LMWH) Injection: An Evidence-Based Practice Project

open access: yesEvidence-Based Nursing Research
Context: Anticoagulation with subcutaneous heparin is the most common treatment for thromboembolic illnesses. LMWH is currently the most popular parenteral anticoagulant drug. Low molecular weight heparins are given by subcutaneous injection.
Faisal A. Alasmari   +7 more
doaj   +1 more source

Targeting the CRYAB/β‐Catenin Axis with an MMP‐9‐Responsive Hydrogel Disrupts CTC Clusters to Suppress Progression of Hepatocellular Carcinoma after Radiofrequency Ablation

open access: yesAdvanced Science, EarlyView.
The graphical abstract illustrates that sublethal thermal stress after iRFA upregulates the chaperone CRYAB in residual HCC cells, which stabilizes β‐catenin and drives a dual pathological program, including EMT and N2‐TAN polarization, thereby leading to heterotypic CTC cluster formation. The MMP‐9‐responsive hydrogel (XB@Gel) delivers XAV‐939 and BMS‐
Hui Chen   +8 more
wiley   +1 more source

Uses of low-molecular-weight heparin.

open access: yes, 1995
Low-molecular-weight-heparin fractions are prepared from standard unfractionated heparin and are thus similar to unfractionated heparin in many aspects.
Bounameaux H, Goldhaber SZ
core   +1 more source

Low incidence of heparin-induced skin lesions in orthopedic surgery patients with low-molecular-weight heparins. [PDF]

open access: yes, 2018
BACKGROUND Heparins are widely prescribed for prevention and therapy of arterial and venous thromboembolic diseases. Heparin-induced skin lesions are the most frequent adverse effect of subcutaneous heparin treatment in non-surgical patients (7.5%-39 ...
Schindewolf, Marc   +19 more
core   +1 more source

Home - About - Disclaimer - Privacy